TV beauty shopping on the rise
This article was originally published in The Rose Sheet
Executive Summary
Women spent more money in the past year on makeup, skin care and fragrance sold through TV networks and infomercials than in the department store and dermatologist channels, according to an online survey conducted in November by the NPD Group. About 4% of beauty shoppers report doing so via television, the market research firm says. Of those women watching shopping channels QVC and HSN, 80% report buying products if they watch. Shopping on television can occur at all hours, and women take advantage of this - 40% reporting that they usually shop between 10 p.m. and 2 a.m. NPD's Senior Global Industry Analyst and VP-Beauty Karen Grant says TV shopping could be an important channel in the straitened economy. "By leveraging the peak time of shopping and other core elements of its appeal, TV networks and infomercials stand to benefit as a complementary vehicle to help fuel in-store sales, particularly in makeup and skincare," she says
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.